Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Ophthalmology
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:category |
gptkb:C
|
| gptkbp:class |
gptkb:Android
|
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:clinical_use |
short-term treatment
long-term treatment not recommended |
| gptkbp:community_service |
safety not established
|
| gptkbp:contraindication |
bacterial infections of the eye
fungal infections of the eye viral infections of the eye |
| gptkbp:dosage_form |
gptkb:cream
|
| gptkbp:drug_interactions |
antibiotics
antiviral medications other corticosteroids |
| gptkbp:excretion |
urine
|
| gptkbp:financial_support |
shake well before use
do not touch dropper tip report any vision changes |
| gptkbp:form |
emulsion
|
| https://www.w3.org/2000/01/rdf-schema#label |
Durezol
|
| gptkbp:indication |
uveitis
postoperative inflammation |
| gptkbp:ingredients |
gptkb:difluprednate
|
| gptkbp:lifespan |
3 to 5 hours
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:marketed_as |
gptkb:2010
|
| gptkbp:mechanism_of_action |
anti-inflammatory
|
| gptkbp:metabolism |
liver
|
| gptkbp:packaging |
gptkb:bottle
|
| gptkbp:patient_education |
inform about potential side effects
advise on proper administration technique encourage adherence to prescribed regimen |
| gptkbp:provides_guidance_on |
follow prescribing information
assess for infection consider alternative therapies monitor intraocular pressure |
| gptkbp:requires |
prescription only
|
| gptkbp:route_of_administration |
topical
ocular |
| gptkbp:safety |
keep out of reach of children
not for injection discard after 28 days of opening not for oral use |
| gptkbp:side_effect |
swelling
discomfort redness stinging burning blurred vision eye irritation increased intraocular pressure |
| gptkbp:storage |
room temperature
|
| gptkbp:used_for |
treating inflammation in the eye
|
| gptkbp:bfsParent |
gptkb:Bausch_+_Lomb_Eye_Products_Ltd.
gptkb:Valeant_Pharmaceuticals |
| gptkbp:bfsLayer |
6
|